All News #Library
Biotech
CK0804 Cuts Spleen Volume, Transfusions in Myelofibrosis
10 Dec 2025 //
PR NEWSWIRE
Cellenkos Showcases CK0804 Phase 1b Data For Myelofibrosis
10 Dec 2024 //
GLOBENEWSWIRE
Cellenkos Announces to Present at ASH on CK0804 in Myelofibrosis
07 Nov 2024 //
PR NEWSWIRE
Cellenkos Approved to Proceed with CK0803 Neurotrophic T regulatory Cell therapy
19 Feb 2024 //
PR NEWSWIRE
Cellenkos Announces First Patient Dosed with CK0803 Cell Therapy
02 May 2023 //
PR NEWSWIRE

Market Place
Sourcing Support